An Extension Study of ABBV-8E12 in Early Alzheimer's Disease (AD)
Clinical trial NCT03712787 · TERMINATED
Trial details
- NCT number
- NCT03712787
- Sponsor
- AbbVie
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-22
- Primary completion
- 2021-09-30
- Enrollment
- 364
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.